Inhaled JAK inhibitor GDC-0214 reduces exhaled nitric oxide in patients with mild asthma: A randomized, controlled, proof-of-activity trial-Reference-Cited by-同舟云学术

Inhaled JAK inhibitor GDC-0214 reduces exhaled nitric oxide in patients with mild asthma: A randomized, controlled, proof-of-activity trial

Published:2021-09 Issue:3 Volume:148 Page:783-789
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Braithwaite Irene E.,Cai Fang,Tom Jennifer A.,Galanter Joshua M.,Owen Ryan P.,Zhu Rui,Williams Mathew,McGregor Anna G.,Eliahu Avi,Durk Matthew R.,Dengler Hart S.,Zak Mark,Kenny Jane R.,Wilson Maria E.,Beasley Richard,Chen Hubert

Funder

Genentech Inc

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference36 articles.

1. After asthma: redefining airways diseases;Pavord;Lancet,2018

2. Asthma phenotypes: the evolution from clinical to molecular approaches;Wenzel;Nat Med,2012

3. The immunology of asthma;Lambrecht;Nat Immunol,2015

4. Type 2 inflammation in asthma--present in most, absent in many;Fahy;Nat Rev Immunol,2015

5. Mepolizumab treatment in patients with severe eosinophilic asthma;Ortega;N Engl J Med,2014

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. JAK inhibitor selectivity: new opportunities, better drugs?;Nature Reviews Rheumatology;2024-09-09

2. Molecular Pathways and Potential Therapeutic Targets of Refractory Asthma;Biology;2024-08-01

3. Biologics in Asthma;Immunology and Allergy Clinics of North America;2024-08

4. Reshaping respiratory care: potential advances in inhaled pharmacotherapy in asthma;Expert Opinion on Pharmacotherapy;2024-07-23

5. Les phénotypes patients : regards du dermatologue et allergologue sur le traitement des patients atteints de DA selon leur profil atopique;Annales de Dermatologie et de Vénéréologie - FMC;2024-06